Fecal calprotectin is an early predictor of endoscopic response and histologic remission after the start of vedolizumab in inflammatory bowel disease

por Pauwels, Renske W. M., van der Woude, Christien J., Erler, Nicole S., de Vries, Annemarie C.
Publicado 2020

Modulation of Indoleamine 2,3-Dioxygenase 1 During Inflammatory Bowel Disease Activity in Humans and Mice

por Proietti, Elisa, Pauwels, Renske W.M., de Vries, Annemarie C., Orecchini, Elena, Volpi, Claudia, Orabona, Ciriana, Peppelenbosch, Maikel P., Fuhler, Gwenny M., Mondanelli, Giada
Publicado 2023

Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease

por Pauwels, Renske W M, Proietti, Elisa, van der Woude, Christien J, Oudijk, Lindsey, Crombag, Marie-Rose B S, Peppelenbosch, Maikel P, Grohmann, Ursula, Fuhler, Gwenny M, de Vries, Annemarie C
Publicado 2021

Ustekinumab Tissue and Serum Levels in Patients With Crohn’s Disease Are Closely Correlated Though Not Consistently Associated With Objective Response After Induction

por Proietti, Elisa, Pauwels, Renske W M, van der Woude, Christien J, Doukas, Michael, Oudijk, Lindsey, Peppelenbosch, Maikel P, Grohmann, Ursula, Crombag, Marie-Rose B S, de Vries, Annemarie C, Fuhler, Gwenny M
Publicado 2022

Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn’s Disease Patients in Stable Remission: The Randomized Controlled LADI Trial

por Jansen, Fenna M, van Linschoten, Reinier C A, Kievit, Wietske, Smits, Lisa J T, Pauwels, Renske W M, de Jong, Dirk J, de Vries, Annemarie C, Boekema, Paul J, West, Rachel L, Bodelier, Alexander G L, Gisbertz, Ingrid A M, Wolfhagen, Frank H J, Römkens, Tessa E H, Lutgens, Maurice W M D, van Bodegraven, Adriaan A, Oldenburg, Bas, Pierik, Marieke J, Russel, Maurice G V M, de Boer, Nanne K, Mallant-Hent, Rosalie C, ter Borg, Pieter C J, van der Meulen-de Jong, Andrea E, Jansen, Jeroen M, Jansen, Sita V, Tan, Adrianus C I T L, Hoentjen, Frank, van der Woude, C Janneke
Publicado 2023